S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13

Glucose Health Stock Forecast, Price & News

-0.08 (-3.60%)
(As of 12/3/2021 03:53 PM ET)
Today's Range
50-Day Range
52-Week Range
8,782 shs
Average Volume
21,780 shs
Market Capitalization
$27.84 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive GLUC News and Ratings via Email

Sign-up to receive the latest news and ratings for Glucose Health and its competitors with MarketBeat's FREE daily newsletter.

Glucose Health logo

About Glucose Health

Glucose Health, Inc. manufactures dietary supplements under the brand GLUCODOWN. The company was founded by Ghislaine St-Hillarie and Roger Corriveau on March 27, 2007 and is headquartered in Bentonville, AR.


See More Headlines

Industry, Sector and Symbol

Medicinals & botanicals
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$290 thousand


Pretax Margin




Free Float
Market Cap
$27.84 million
Not Optionable

Company Calendar

Fiscal Year End


Overall MarketRank

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Glucose Health (OTCMKTS:GLUC) Frequently Asked Questions

Are investors shorting Glucose Health?

Glucose Health saw a drop in short interest in the month of November. As of November 15th, there was short interest totaling 500 shares, a drop of 58.3% from the October 31st total of 1,200 shares. Based on an average daily volume of 45,600 shares, the days-to-cover ratio is currently 0.0 days.
View Glucose Health's Short Interest

Who are Glucose Health's key executives?

Glucose Health's management team includes the following people:
  • Murray S. Fleming, Director, Chief Executive & Financial Officer
  • Peggy Freeman Knight, Head-Marketing & Branding
  • Judith C. Nostrund, Head-Accounting & Audit

What other stocks do shareholders of Glucose Health own?

What is Glucose Health's stock symbol?

Glucose Health trades on the OTCMKTS under the ticker symbol "GLUC."

How do I buy shares of Glucose Health?

Shares of GLUC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Glucose Health's stock price today?

One share of GLUC stock can currently be purchased for approximately $2.01.

How much money does Glucose Health make?

Glucose Health has a market capitalization of $27.84 million and generates $290 thousand in revenue each year.

How many employees does Glucose Health have?

Glucose Health employs 147,000 workers across the globe.

What is Glucose Health's official website?

The official website for Glucose Health is www.glucosehealthinc.com.

Where are Glucose Health's headquarters?

Glucose Health is headquartered at 609 SW 8TH STREET 6TH FLOOR, BENTONVILLE AR, 72712.

How can I contact Glucose Health?

Glucose Health's mailing address is 609 SW 8TH STREET 6TH FLOOR, BENTONVILLE AR, 72712. The company can be reached via phone at (479) 802-3827 or via email at [email protected].

This page was last updated on 12/4/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.